MY190158A - Burkholderia pseudomallei outer membrane protein a - Google Patents
Burkholderia pseudomallei outer membrane protein aInfo
- Publication number
- MY190158A MY190158A MYPI20082707A MYPI20082707A MY190158A MY 190158 A MY190158 A MY 190158A MY PI20082707 A MYPI20082707 A MY PI20082707A MY PI20082707 A MYPI20082707 A MY PI20082707A MY 190158 A MY190158 A MY 190158A
- Authority
- MY
- Malaysia
- Prior art keywords
- outer membrane
- burkholderia pseudomallei
- burkholderia
- membrane protein
- infection
- Prior art date
Links
- 241001136175 Burkholderia pseudomallei Species 0.000 title abstract 3
- 108010079246 OMPA outer membrane proteins Proteins 0.000 title 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 2
- 241001453380 Burkholderia Species 0.000 abstract 1
- 206010073031 Burkholderia infection Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000002480 immunoprotective effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
This invention discloses the immunogenic outer membrane proteins of the pathogen, Burkholderia pseudomallei for use in prevention and treatment of Burkholderia spp. infection. Two recombinant outer membrane proteins A of Burkholderia pseudomallei, Omp3 and Omp7 were identified to induce immunoprotective response against Burkholderia infection.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20082707A MY190158A (en) | 2008-07-21 | 2008-07-21 | Burkholderia pseudomallei outer membrane protein a |
| SG200808749-6A SG158788A1 (en) | 2008-07-21 | 2008-11-26 | Burkholderia pseudomallei outer membrane protein a |
| SG2011087152A SG176520A1 (en) | 2008-07-21 | 2008-11-26 | Burkholderia pseudomallei outer membrane protein a |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20082707A MY190158A (en) | 2008-07-21 | 2008-07-21 | Burkholderia pseudomallei outer membrane protein a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY190158A true MY190158A (en) | 2022-03-31 |
Family
ID=41716841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20082707A MY190158A (en) | 2008-07-21 | 2008-07-21 | Burkholderia pseudomallei outer membrane protein a |
Country Status (2)
| Country | Link |
|---|---|
| MY (1) | MY190158A (en) |
| SG (2) | SG176520A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250263447A1 (en) * | 2020-09-04 | 2025-08-21 | Intravacc B.V. | Ompa mutations enhance omv production in bordetella pertussis |
-
2008
- 2008-07-21 MY MYPI20082707A patent/MY190158A/en unknown
- 2008-11-26 SG SG2011087152A patent/SG176520A1/en unknown
- 2008-11-26 SG SG200808749-6A patent/SG158788A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG176520A1 (en) | 2011-12-29 |
| SG158788A1 (en) | 2010-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201170493A1 (en) | MICROORGANISMS AND VACCINES DEPENDING ON REPLICATION OF NON-NATURAL AMINO ACIDS | |
| MX2010002318A (en) | 2,3-substituted azaindole derivatives for treating viral infections. | |
| GB0710529D0 (en) | Vaccine | |
| NZ596805A (en) | Meningococcal fHBP polypeptides | |
| MX2009008617A (en) | Use of il-23 antagonists for treatment of infection. | |
| IN2012DN02737A (en) | ||
| MX2012000035A (en) | Recombinant rsv antigens. | |
| WO2010083347A3 (en) | Peptidomimetic macrocycles | |
| MX338898B (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant. | |
| IL213861A0 (en) | Cyclosporine derivative for use in the treatment of hcv and hiv infection | |
| MY151051A (en) | Vaccination against dengue virus infection | |
| SG158145A1 (en) | Vaccines against chlamydial infection | |
| GB2453491A (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof | |
| EA201290956A1 (en) | VACCINE AGAINST HIV | |
| WO2010034974A3 (en) | Tuberculosis vaccines targeted to cd40 | |
| EA201171186A1 (en) | SOKRISTALL ETRAVIRIN AND NICOTINAMIDE | |
| MY172788A (en) | Influenza vaccines | |
| WO2011098778A8 (en) | Peptides for vaccines against birch allergy | |
| EA201171001A1 (en) | HERBAL PEPTIDES FOR VACCINE | |
| WO2012061248A3 (en) | Novel specific hcv ns3 protease inhibitors | |
| MX342832B (en) | Treatment or prevention of infection. | |
| MX347911B (en) | Bvdv vaccine. | |
| WO2010041241A3 (en) | Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding | |
| MX2009009743A (en) | Powders for reconstitution. | |
| IL194353A0 (en) | Lysobactin amides |